Research note: Ethics of drug treatment research with court-supervised subjects
Research note: Ethics of drug treatment research with court-supervised subjects
复制标题
DOI：
10.1177/002204260403400414
复制
发表时间：
2004-09-01
影响因子：
1.7
通讯作者：
Salmon, C
中科院分区：
文献类型：
--
作者：
DuVal, G;Salmon, C
在过去的二十年里，成瘾性疾病的临床研究和治疗进展加速。这一领域的许多重要研究都需要受试者的参与，这些受试者本身就患有药物依赖性，而且在某个时候极有可能卷入刑事司法系统。然而，在药物研究中使用受法院监督的成瘾性疾病患者会引起一些重大的伦理问题。这些问题包括，除其他外，对个人提供有能力的、自愿的、知情同意的能力以及研究人员保护敏感临床信息的义务的担忧。各种潜在的胁迫因素可能影响法院监督的人决定是否参加研究，并可能损害他们提供知情同意的能力。在本文中，我们探讨了在这项研究中出现的伦理问题，并提供了一些建议，以解决这些问题的方法。
The last two decades have seen an acceleration of clinical research on, and treatment advances in, addictive illness. Much important research in this area requires the participation of subjects who themselves suffer from drug dependence and have a strong likelihood of becoming involved in the criminal justice system at some point. However, using court-supervised persons with addictive disorders in drug research raises a number of significant ethical issues. These include, among others, worries about the individual's ability to provide capable, voluntary, informed consent and the obligation of researchers to safeguard sensitive clinical information. A variety of potentially coercive factors can influence court-supervised persons in their decision whether to enter research and can compromise their ability to provide informed consent. In this paper, we explore the ethical issues arising in this research and offer some suggestions for approaches to address these concerns.